Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Pim
    (7)
  • Apoptosis
    (2)
  • Autophagy
    (1)
  • CDK
    (1)
  • Casein Kinase
    (1)
  • FLT
    (1)
  • GSK-3
    (1)
  • Src
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

pim-in-2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    11
    TargetMol | Inhibitors_Agonists
PIM-IN-2
T814601006699-45-1
PIM-IN-2 (Pim-2) is a potent inhibitor of Pim kinases with an IC50 value of 25 nM, exhibiting antiapoptotic properties that promote cell survival and show elevated expression levels in various human tumors [1].
  • Inquiry Price
8-10 weeks
Size
QTY
PIM-1/CK2-IN-2
T201217
PIM-1 CK2-IN-2 (compound 3aA) is an inhibitor of the PIM-1 CK2 enzymes. This compound can induce the mitochondrial apoptosis pathway in CCRF-CEM cells and is utilized in cancer research.
  • Inquiry Price
Size
QTY
HJ-PI01
N-Acetylphenoxazine, 10-acetylphenoxazine
T95836192-43-4In house
HJ-PI01 (HJ-PI01) is a Pim-2 inhibitor. HJ-PI01 (HJ-PI01) induces apoptosis and autophagic cell death in triple-negative human breast cancer.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Pim-1/2 kinase inhibitor 1
T92296320-51-0
Pim-1 2 Kinase Inhibitor 1, an orally active inhibitor, impedes the action of Pim kinases by preventing their ability to phosphorylate peptides. It particularly inhibits the phosphorylation of 4E-BP1 and p27 Kip1 by Pim protein kinases. This compound is valuable in cancer research, with a notable application in studying prostate cancer [1].
  • Inquiry Price
7-10 days
Size
QTY
TargetMol | Inhibitor Sale
Protein kinase inhibitor 11
T205016721964-51-8
Protein kinase inhibitor 11 (Compound I-96) is an agent that inhibits the activity of PIM-1, CDK-2, GSK-3, and SRC. It shows potential for research in cancer, autoimmune diseases, and neurodegenerative disorders.
  • Inquiry Price
10-14 weeks
Size
QTY
PIM-1 Inhibitor 2
PIM1-IN-2
T23158477845-12-8
PIM-1 Inhibitor 2 (PIM1-IN-2) is a potent Pim-1 inhibitor with potential anti-cancer activity, used in cancer research.
  • Inquiry Price
6-8 weeks
Size
QTY
SGI-1776
SGI-1776 free base, Pim-Kinase Inhibitor IX
T30781025065-69-3
SGI-1776 (Pim-Kinase Inhibitor IX) has been used in trials studying the treatment of Prostate Cancer, Non-Hodgkins Lymphoma, and Relapsed Refractory Leukemias.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
hs56
T68341922050-57-5
HS56 is an ATP-competitive dual Pim DAPK3 inhibitor, displaying K_i values of 0.26 μM for DAPK3, 0.208 μM for Pim-3, 2.94 μM for Pim-1, and >100 μM for Pim-2. This compound effectively inhibits LC20 phosphorylation and smooth muscle contraction, and reduces blood pressure in spontaneously hypertensive mice, making it a valuable tool for hypertension research [HS-56].
  • Inquiry Price
6-8 weeks
Size
QTY
QLT0267
T84998866409-68-9
QLT0267 is an inhibitor targeting integrin-linked kinase (ILK; IC50= 26 nM), showing over 10-fold selectivity against cyclin-dependent kinases 1, 2, and 5 (Cdk1, Cdk2, and Cdk5), and over 1,000-fold selectivity against C-terminal Src kinase (CSK), DNA-PK, Pim-1, Akt, PKC, and casein kinase 2 (CK2) at a concentration of 10 mg/ml. This compound effectively inhibits the proliferation of NPA187 papillary thyroid cancer cells with an IC50 of approximately 3 µM and induces apoptosis in NPA187, DRO, and K4 cancer cell lines. In vivo studies reveal that QLT0267, administered at 100 mg/kg, significantly reduces tumor growth in a DRO mouse xenograft model and diminishes both tumor volume and intratumoral vascularization in a U87MG glioblastoma mouse xenograft model, showcasing its potential for therapeutic applications in cancer treatment.
  • Inquiry Price
35 days
Size
QTY
IBL-302
AMU302
T866981414455-21-2
IBL-302 (AMU302), an orally available dual-signaling inhibitor targeting PIM and PI3K AKT mTOR, is effective against breast cancer and neuroblastoma. It has shown in vivo efficacy in a nude mouse xenograft model by combating trastuzumab resistance. Additionally, IBL-302 augments the effectiveness of widely used cytotoxic chemotherapy drugs such as cisplatin, doxorubicin, and etoposide [1] [2] [3].
  • Inquiry Price
10-14 weeks
Size
QTY
Pim-1/2 kinase inhibitor 2
T872142918764-16-4
Compound 5b, designated as Pim-1 2 kinase inhibitor 2, acts as a competitive inhibitor of both PIM-1 and PIM-2 kinases, demonstrating IC50 values of 1.31 μM and 0.67 μM, respectively. This compound exhibits potent in-vitro anticancer activity against various cancer cell lines, including myeloid leukemia (NFS-60), liver (HepG-2), prostate (PC-3), and colon (Caco-2), while showing low cytotoxicity to the normal human lung fibroblast Wi-38 cell line [1].
  • Inquiry Price
10-14 weeks
Size
QTY